Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.e

Organizing pneumonia pattern (an area or areas of consolidation on imaging)

Publications

Banka R, Ward MJ

Bronchiolitis obliterans and organising pneumonia caused by carbamazepine and mimicking community acquired pneumonia.

Postgraduate medical journal 2002 Oct;78;621-2 — 2002 Oct — 621-2

Milesi-Lecat AM, Schmidt J, Aumaitre O, Kemeny JL, Moinard J, Piette JC

Lupus and pulmonary nodules consistent with bronchiolitis obliterans organizing pneumonia induced by carbamazepine.

Mayo Clinic proceedings 1997 Dec;72;1145-7 — 1997 Dec — 1145-7

Angle P, Thomas P, Chiu B, Freedman J

Bronchiolitis obliterans with organizing pneumonia and cold agglutinin disease associated with phenytoin hypersensitivity syndrome.

Chest 1997 Dec;112;1697-9 — 1997 Dec — 1697-9

Purcell IF, Bourke SJ, Marshall SM

Cyclophosphamide in severe steroid-resistant bronchiolitis obliterans organizing pneumonia.

Respiratory medicine 1997 Mar;91;175-7 — 1997 Mar — 175-7